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OBJECTIVES We sought to investigate the possible pathogenetic role of myocardial trace elements (TE) in
patients with various forms of cardiac failure.
BACKGROUND Both myocardial TE accumulation and deficiency have been associated with the development
of heart failure indistinguishable from an idiopathic dilated cardiomyopathy.
METHODS Myocardial and muscular content of 32 TE has been assessed in biopsy samples of 13 patients
(pts) with clinical, hemodynamic and histologic diagnosis of idiopathic dilated cardiomyop-
athy (IDCM), all without past or current exposure to TE. One muscular and one left
ventricular (LV) endomyocardial specimen from each patient, drawn with metal
contamination-free technique, were analyzed by neutron activation analysis and compared
with 1) similar surgical samples from patients with valvular (12 pts) and ischemic (13 pts)
heart disease comparable for age and degree of LV dysfunction; 2) papillary and skeletal
muscle surgical biopsies from 10 pts with mitral stenosis and normal LV function, and 3) LV
endomyocardial biopsies from four normal subjects.
RESULTS A large increase (.10,000 times for mercury and antimony) of TE concentration has been
observed in myocardial but not in muscular samples in all pts with IDCM. Patients with
secondary cardiac dysfunction had mild increase (#5 times) of myocardial TE and normal
muscular TE. In particular, in pts with IDCM mean mercury concentration was 22,000 times
(178,400 ng/g vs. 8 ng/g), antimony 12,000 times (19,260 ng/g vs. 1.5 ng/g), gold 11 times
(26 ng/g vs. 2.3 ng/g), chromium 13 times (2,300 ng/g vs. 177 ng/g) and cobalt 4 times (86,5
ng/g vs. 20 ng/g) higher than in control subjects.
CONCLUSIONS A large, significant increase of myocardial TE is present in IDCM but not in secondary
cardiac dysfunction. The increased concentration of TE in pts with IDCM may adversely
affect mitochondrial activity and myocardial metabolism and worsen cellular function. (J Am
Coll Cardiol 1999;33:1578–83) © 1999 by the American College of Cardiology
Idiopathic dilated cardiomyopathy (IDCM) is, by defini-
tion, a disease characterized by dilation and impaired
contraction of the left or both ventricles. Its etiology is still
unknown and the pathogenetic mechanism debated, al-
though a viral and/or immune, genetic/familial or toxic
mechanism has been suggested (1–8).
Trace elements (TE) are known to have a key role in
myocardial metabolism and both TE accumulation (cobalt,
arsenic) and deficiency (selenium, i.e., Keshan disease) may
be responsible for a dilated cardiomyopathy indistinguish-
able from an idiopathic form (9,10). It has been docu-
mented that even a Coxsackie viral infection can cause a
great TE accumulation in the mouse heart (11,12).
To investigate the possible pathogenetic role of TE in
IDCM, 32 TE were assessed by neutron activation analysis
in left ventricular (LV) endomyocardial and muscular biopsy
specimens from patients with IDCM and specific forms of
cardiac dysfunction.
METHODS
Patient population. Thirteen patients (9 male, 4 female,
mean age 50.9 6 10.1 years) with IDCM (group A) were
included in the study (Table 1). The patients were admitted
to our institution because of dyspnea (New York Heart
Association class II–IV) and palpitation. No patients had
hypertension, drug or alcohol abuse, ischemic heart disease
or systemic disorders. All patients underwent noninvasive
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(electrocardiography, two-dimensional echocardiography
and Holter monitoring) and invasive (cardiac catheteriza-
tion, coronary arteriography and left ventricular endomyo-
cardial biopsy) cardiac studies. Endomyocardial biopsies
were performed in the septal–apical region of left ventricle,
which was approached by a 7-F (501-613A Cordis) long
sheet and identified on an X-ray view using flashing of
contrast medium (iohexol, Omnipaque, Nycomed). Three
to four left ventricular samples were drawn, processed for
histology and electron microscopy and read by a pathologist
blinded to the clinical data. Specifically, the tissue speci-
mens for light microscopy were fixed in 10% buffered
formaline, and embedded in paraffin wax; 5-mm thick
sections were cut and stained with hematoxylin–eosin,
Miller’s elastic Van Gieson and Masson’s trichrome. For
electron microscopy all samples of myocardial tissue were
fixed in a solution of 2% glutaraldehyde in a 0.1 mol/L
phosphate buffer, at pH 7.3 and embedded in an Epon resin
following a standard schedule. Ultrathin sections were
stained with uranyl acetate and lead citrate.
Morphometry, using a grid and point and counting
system (13), was applied on histologic slides to assess the
extent of myocardial fibrosis, and its prevalence was corre-
lated with the degree of impairment of cardiac function (LV
ejection fraction) and the myocardial content of TE.
A second correlative study was also performed on the
myocardial content of the TE and the arrhythmic profile of
each patient (Lown class) based on the results of Holter
recordings (3 to 5 each patient) and/or electrocardiographic
findings during hospital admissions. Needle muscle biopsies
of vastus lateralis muscle were performed using a Bard
Biopsy instrument with a 14-gauge needle as described (14)
in patients with IDCM. Environmental exposure to heavy
metals and toxic TE was assessed by means of a question-
naire.
Control samples for histology, morphometry and TE
analysis were:
Group B: Left ventricular endomyocardial and thoracic
muscle biopsy samples from 12 patients (eight male,
four female mean age 53 6 10 years) with valvular
heart disease (mitral regurgitation in four patients
aortic stenosis in three patients, aortic regurgitation in
two patients, aortic stenosis and regurgitation in three
patients) left ventricular dilation (left ventricular end-
diastolic diameter [LVEDD] 5 69.5 6 7.48 mm) and
depressed LV function (left ventricular ejection frac-
tion [LVEF] 5 30 6 6.3%) obtained during the
surgical replacement of the valve; left ventricular
endomyocardial and thoracic muscle biopsies from 13
patients (10 male, three female, mean age 58.8 6 9.7
years) with ischemic heart disease, LV dilation
(LVEDD 5 67.3 6 4.8 mm) and LV dysfunction
(LVEF 5 33 6 4%) taken at the time of coronary
artery bypass surgery.
Group C. Papillary and thoracic muscular biopsies from
10 patients (five male, five female mean age 55.2 6
8.6 years) with mitral stenosis and normal LV dimen-
Abbreviations and Acronyms
Ag 5 silver
As 5 arsenic
Ca 5 calcium
Hg 5 mercury
IDCM 5 idiopathic dilated cardiomyopathy
LV 5 left ventricle
LVEDD 5 left ventricular end-diastolic diameter
LVEF 5 left ventricular ejection fraction
pts 5 patients
Sb 5 antimony
TE 5 trace elements
Table 1. Data on 13 Patients With Idiopathic Dilated Cardiomyopathy
Pts Age/Gender
NYHA
Class
LVEDD
(mm) LVEF
CI
(liters/min/m2) Fibrosis
Ventricular
Arrhythmias
(Lown Class)
Hg (ng/g)
in My
Sb
(ng/g)
in My
1 31/M III 75 25% 2.0 3.1% 4b (nsVT) 108,000 18,200
2 41/F I 70 35% 2.3 7.5% 3 52,700 3,600
3 59/M IV 78 18% 1.8 3.4% 4b (nsVT) 160,000 32,500
4 54/M I 68 40% 2.4 6% 2 49,000 6,500
5 51/M II 70 30% 2.1 5.5% 3 91,800 29,900
6 43/M II 66 32% 2.3 9.5% 3 42,200 11,000
7 54/M III 74 20% 1.9 3% 2 9,300 2,000
8 65/M III 80 25% 2.0 6.5% 4b (nsVT) 176,700 36,900
9 62/F II 71 39% 2.5 3.5% 3 44,800 4,500
10 59/F III 76 25% 2.1 5.75% 4b (sVT) 865,000 98,800
11 55/F III 73 22% 2.0 4.5% 4b (sVT) 409,000 49,500
12 37/M IV 80 18% 1.7 3% 4b (nsVT) 225,000 37,200
13 41/M I 65 42% 2.6 5.5% 3 86,000 5,500
CI 5 cardiac index; EDD 5 end-diastolic diameter; EF 5 ejection fraction; Hg 5 mercury; LV 5 left ventricular; My 5 myocardium; ns 5 nonsustained; NYHA 5 New
York Heart Association; Pts 5 patients; s 5 sustained; VT 5 ventricular tachycardia.
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sion (LVEDD 5 48.2 6 2.6 mm) and function
(LVEF 5 56.1 6 4.4%) undergoing mitral valve
replacement (control subjects).
Group D. Normal LV endomyocardial biopsies (section
of specimens with normal histologic findings) from
four patients (two male, two female, mean age 54 6
4.5 years) who underwent a diagnostic cardiac cathe-
terization with ventricular and coronary angiography
because of chest pain, which showed normal coronary
arteries, LV volumes and LV function. Moreover, in
order that a uniform procedure was followed, biopsy
specimens were taken from patients and control sub-
jects using a Bipal Cordis bioptome.
Trace elements assessment. One ventricular biopsy spec-
imen (weight range: 1.5 to 2.8 mg/wet weight) was pro-
cessed to determine the levels of TE by neutron activation
analysis (15). The following elements were analyzed: silver
(Ag), arsenic (As), gold, barium, calcium (CA), cadmium,
cerium, cobalt, chromium, cesium, eruopium, iron, haf-
nium, mercury (Hg), iridium, lanthanum, lutetium, molib-
denum, nickel, rubidium, antimony (Sb), scandium, sele-
nium, samarium, tin, strontium, tantalum, terbium,
thorium, uranium, ytterbium, zinc and zirconium.
When metallic surgical instruments are used to collect
human tissue, metal contamination may occur, thus making
it difficult to assess accurately the levels of ultratrace metal
elements (16). To reduce this bias as much as possible,
surgical instruments made from a stainless-steel core cov-
ered by a film of titanium nitride (a very hard compound
with a high chemical stability and very good wear resistance)
were used. Samples were kept frozen until irradiation.
The observed values were compared with control samples
and with data from the literature (17–19).
Statistical analysis. Data were analyzed by means of
SPSS/PC1 (Cary, North Carolina). Continuous data were
summarized as mean 6 SD. The difference between two
groups was tested by Mann-Whitney U test. The relation
between continuous variables was assessed by the method of
the least squares. A two-tailed p value , 0.05 was consid-
ered significant.
RESULTS
No cases of occupational exposure to TE were observed,
not did any patients or control subjects come from heavily
polluted geographic areas.
Clinical study. Echocardiography showed an increase of
LVEDD (72.7 6 4.9 mm) and a significant impairment of
left ventricular function (LVEF 5 28.5% 6 8.4%). No
significant valvular abnormalities were present.
Holter monitoring revealed in all patients frequent ven-
tricular ectopic beats with some couples and triplets and in
six cases phases of nonsustained or sustained ventricular
tachycardia (Lown class 4b) (Table 1). We performed a
Holter monitoring also in control subjects with secondary
cardiac dysfunction, which failed to show repetitive ventric-
ular ectopic beats (Lown #3). Cardiac catheterization and
left ventriculography confirmed the compromised global
contractility with reduction of cardiac index and elevation of
left ventricular filling pressure (Table 1). Coronary angiog-
raphy showed a normal arteriogram in every case.
Histology of left ventricular biopsy fragments from each
patient ruled out specific heart muscle diseases such as
myocarditis, and storage or infiltrative heart muscle diseases,
while showing signs of hypertrophy with attenuation and
degenerative changes of myocardial fibers.
Electron microscopy showed degenerative changes to
consist of loss of contractile elements, the presence of
myelin bodies and the vacuolization of mitochondria with
fragmentation of mitochondrial cristae.
Myocardial and muscle TE concentration. In the major-
ity of cases, in both patients and control subjects, myocardial
concentrations of Ca, cadmium, hafnium, iridium, lutetium,
molibdenum, samarium, tin, strontium, tantalum, terbium,
thorium, uranium, ytterbium and zirconium appeared to be
below the lower analytical determination limit. In control
subjects, concentrations of cerium, cesium, europium, nickel
and scandium were below the determination limit. Mean
concentration values of the remaining 13 elements in
patients (groups A and B) and controls (group C) are shown
in Table 2. The mean concentration of these TE was in the
range of normal reference values (18) both in control
subjects (group C) and in the four normal subjects (group
D).
A severe increase in Hg and Sb was observed in IDCM
patients (patients/control subjects ratio .10,000). In addi-
tion, Ag, As, gold, chromium, lanthanum and zinc levels
were 10 to 250 times higher in patients than in control
subjects. Trace elements concentrations in papillary muscle
biopsies were within the normal range of variation.
In IDCM patients the mean concentrations were 178,400
ng/g for Hg, 19,260 ng/g for Sb and 625 ng/g for As,
whereas corresponding values in normal control subjects
were 8 ng/g, 1.5 ng/g and 2.5 ng/g respectively. In patients
with specific forms of cardiac dysfunction the mean con-
centration of Hg was 30 ng/g in patients with valvular heart
disease and 23 ng/g in patients with ischemic heart disease,
of Sb was 6 ng/g and 6.5 ng/g and of As was 9.3 and 10.3
respectively (Table 2). Corresponding reference interval
values in published reports were 5 to 480 ng/g for Hg, 2 to
35 ng/g for Sb and 4.4 to 14 ng/g for As in myocardial tissue
(18).
The values given are well above the normal range.
Moreover, the Hg soft tissue body burden of Hg in a
reference man weighing 70 kg is estimated to be 13 mg, and
the total body burden of Sb is about 1 mg (20). In IDCM
patients a simple calculation reveals up to 17.8 mg/100 g of
heart tissue for Hg, and 1.9 mg/100 g for Sb, thus showing
that these TE are stored abnormally in myocardial tissue.
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No correlation was found between the concentrations of
each TE and the age of the patient. The correlation
coefficients between TE and age did not reach the statistical
level of significance (correlation coefficients for Hg 5 0.25,
p 5 0.42; for Sb 5 0.26, p 5 0.39).
No differences were observed in the levels of myocardial
TE in male and female subjects (p 5 0.44 for Hg; p 5 0.76
for Sb).
The degree of myocardial fibrosis, assessed by micro-
scopic examination of histologic fields, was mild to moder-
ate (#9.5%) and did not appear to be correlated with Hg or
Sb concentrations (correlation coefficients for Hg 5 20.03,
p 5 0.92; for Sb 5 20.05, p 5 0.87).
Patients with higher concentrations of myocardial TE
appeared to have a more pronounced degree of LV impair-
ment and electrical instability (see Table 1). Those with the
most pronounced degree of LV impairment (LVEF ,0.30)
had higher average concentrations of Hg (279 vs. 61 ng/g,
p 5 0.03) and Sb (39.3 vs. 10.2 ng/g, p 5 0.04) than those
with partially preserved myocardial function (LVEF, be-
tween 0.30 and 0.49); patients with sustained and nonsus-
tained ventricular tachycardia showed higher concentrations
of TE than those without (Hg 324 vs. 54 ng/g, p 5 0.0027;
Sb 45.5 vs. 9,0 ng/g, p 5 0.0043).
Skeletal muscle concentrations of the 32 TE examined
were in the normal range in all patients and control subjects.
In particular muscle concentration of Hg and Sb were ,150
ng/g and ,193 ng/g respectively (18).
DISCUSSION
The most relevant result of our study is a large increase of
the myocardial content of some TE in patients with IDCM
not documented in patients with specific heart muscle
disease presenting comparable degree of left ventricular
dysfunction. This increase has an obvious statistical signif-
icance and its biologic significance needs to be evaluated.
Consideration on TE assessment. Most of the data re-
ported in published reports on TE in human tissues are of
limited value in the assessment of their toxicologic impact:
this is due not only to individual biologic variations, but also
to errors caused by analytic inconsistencies (21). Patent
discrepancies can be observed among studies conducted by
spectrographic and neutron activation methods. Neutron
activation analysis has been shown to be the most advanta-
geous method for quantitative determination of TE in
human tissues owning to its high level of precision, high
specificity and high accuracy (22). Particular attention has to
be paid to preanalytic factors, such as ethnic variations,
sampling, sample handling and storage.
Preanalytic factors on TE assessment. The range of
values that we considered as normal for myocardial and
muscular content of TE is argued from a review (18) of
international published data on the elemental composition
of human tissues of healthy, adult individuals from popula-
tions of different ethnicity. We can therefore postulate that
these reference values were appropriate also for our popu-
lation.
Moreover in our study both patients and control subjects
were of the same geographic area and ethnicity (white
Italian people) making unlikely that difference on TE
concentration might be due to different genetic patterns.
Loss of water from small myocardial samples during
analysis could lead to overestimation of the intramyocardial
content of TE; evaporation could be as high as 50% of total
weight. Data interpretation should, therefore, be cautious
and doubled values should be regarded as normal. It would
also take into account the biologic sources of variation. In
Table 2. Mean Myocardial Trace Elements Concentration (ng/g) in Patients With Idiopathic Dilated Cardiomyopathy (Group A),
Secondary Forms of Cardiac Dysfunction (Group B), Control Subjects (Group C) and Normal Subjects (Group D) as Determined by
Neutron Activation Analysis
Element
Normal
Range Group A
Group B
Group C Group D
Ratio
A/CValvular Ischemic
Ag 3.3–260 116 17 13 4 7 29
As 4.4–14 625 9.3 10.3 2.5 4 250
Au 0.045 26 7 11 2.3 3.2 11.3
Ba 7.6–2,020 7,360 6,200 5,300 1,500 1,250 4.9
Co 10–210 86.5 100 89 20 15 4.3
Cr 11–480 2,300 630 720 177 100 13
Fe 36,000–180,000 106,700 130,200 148,700 39,000 34,000 2.7
Hg 5–480 178,400 30 23 8 6 22,300
La 1 43.3 5 3.5 1.2 0.9 36
Rb 1,200–8,100 18,700 3,200 3,565 3,880 3,200 4.8
Sb 2–35 19,260 6 6.5 1.5 1.1 12,840
Se 49–5,000 383 270 230 250 220 1.5
Zn 17,800–113,000 128,000 16,000 21,000 9,000 7,500 14.2
Ag 5 silver; As 5 arsenic; Au 5 gold; Ba 5 barium; Co 5 cobalt; Cr 5 chromium; Fe 5 iron; Hg 5 mercury; La 5 lanthanum; Rb 5 rubidium; Sb 5 antimony; Se 5 selenium;
Zn 5 zinc.
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autopsy studies, postmortem process and contamination of
tissues by residual blood could lead to relatively high errors
for several TE (23); there is, however, no fear of this in our
study.
Gender has not been proved to play a significant role in
the distribution of TE (19), and, in agreement with the
published data our study showed no significant gender
differences in either IDCM patients or control subjects.
The body burden of most elements seems to be influ-
enced significantly by age. Most TE are very low at birth
and build up rapidly thereafter (24–25); after the age of
three months, however, such differences tend to disappear
and, in some studies, no significant differences associated
with age have been obtained (19). The comparison of
myocardial samples from young people (which we used as
our control subjects) and adults may show slight differences
in the levels of TE; an increase of three to four orders of
magnitude, however, cannot depend on physiologic aging.
Another factor to consider is the anatomic distribution of
TE. Differences in the levels of TE in different anatomic
regions of the heart have been reported in animals (26–28),
but at present there is insufficient evidence to suggest that
such a difference occurs in humans. No apparent differences
were noted between the concentrations of TE in different
parts of the ventricular myocardium (19).
Finally a direct or indirect effect of contrast medium on
myocyte TE concentration can be taken into consideration.
Indeed, surgical control samples showing normal TE values
were obtained several days or weeks after catherization and
angiography, whereas biopsy specimens of patients with
IDCM were drawn right after the angiographic study.
Nevertheless TE values observed in normal LV biopsies
from four subjects undergoing an invasive study, including
coronary and ventricular angiography, were found to be
within normal limits. We can therefore reasonably rule out
any effect, due either to TE contamination or to interference
of iodine on the myocardial TE concentration.
In conclusion, the observed increase in the myocardial
content of some TE is likely to reflect a pathologic phe-
nomenon.
Side of myocardial TE increase. The increased concentra-
tions of TE in the myocardium could depend on an increase of
myocardial fibrous tissue, or an increase in endocellular con-
centrations of TE, or both. Morphometry, however, failed to
show a correlation between the degree of myocardial fibrosis
and the levels of TE. It seems, therefore, that myocardial
accumulation of TE in IDCM should be mostly intracellular,
which is in agreement with the extensive pathologic evidence
that points to myocardial cell degeneration and dysfunction,
rather than replacement of myocardiocytes by fibrous tissue, as
the source of failure in IDCM.
Trace elements and ventricular arrhythmias. As far as the
arrhythmic profile of our IDCM patients is concerned, a
similar correlative trend was observed when comparing the
severity of ventricular arrhythmias with myocardial concen-
trations of TE. Although the number of patients studied
may not be representative, the incidence of ventricular
tachycardia seems to be associated with higher values of TE
(Table 1). In fact, in patients with Lown class 4b we found
higher values of Ag and Sb than in patients with Lown class
2–3, and among these patients, No. 10 and No. 11, who
showed episodes of sustained ventricular tachycardia on
Holter monitoring, had the highest values. In patients with
secondary forms of cardiac dysfunction and mild elevation
of TE the Holter monitoring showed only a Lown class #3.
In summary, high increases of some TE in the myocardial
tissue of patients with IDCM seem to correlate with the
severity of cardiac impairment, as well as that of electrical
instability.
Trace elements in IDCM compared with secondary
cardiac dysfunction. In patients with valvular and ischemic
cardiomyopathies having comparable degree of left ventric-
ular dysfunction, only mild (#5 times normal control
subjects) increase of TE was documented. This point
together with the absence of signs and/or symptoms of TE
intoxication and the normal TE values observed on skeletal
muscle biopsies suggest that myocardial TE accumulation is
specifically correlated with the pathogenesis of IDCM itself.
Possible mechanism of TE accumulation in IDCM.
Actually we are unable to explain its mechanism, as dilated
cardiomyopathy remains an idiopathic entity. The more
reliable, although unconfirmed, pathogenetic hypothesis for
IDCM, is that of a virus-induced disease. It has been
documented that a common viral (Coxsackie virus) infection
can change TE target organ distribution in mice with
greatly increased accumulation of nickel (11), cadmium and
mercury (12) in the wall of the ventricular myocardium. We
can speculate that a cardiac viral infection might induce an
impairment of cellular biomembranes, which could, in turn,
increase the input or reduce the output of certain TE,
determining toxic intracellular concentrations.
Potential consequences of TE accumulation in IDCM.
At present, we are unable to establish the toxic threshold
levels of TE in the myocardium, since biopsy data on
patients with toxic TE exposure are not available. The
extremely high values of Hg and Sb found in our patients
with IDCM makes it unlikely that there would be no
adverse effect. Indeed, each of the TE increased in IDCM
myocardial tissue may interfere with cellular activities.
Particularly heavy metals (i.e., Hg, Sb, Ag) whose values
were the most elevated, are known to induce the formation
of oxygen free radicals in the affected tissues (29–31).
Superoxide anions and radicals can, in turn, inhibit cardiac
sodium pump and several other ion transporters of the
plasma membrane (32). The final results may well be the
idropic degeneration and the mitochondrial damage of
myocardiocytes that are observed at histology and electron
microscopy in IDCM.
Finally heavy metals can antagonize Ca11 at actin–
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myosin junction in a concentration-dependent way, produc-
ing a progressive decline of sarcomere contraction and thus
of myocyte function. On pharmacologic grounds, drugs
such as the inotropic agents that work on increasing
intracellular Ca11 may find the reason of their inefficacy in
dilated cardiomyopathy.
Conclusions. The accumulation of some TE seems to be a
constant finding in IDCM but not in specific cardiomyop-
athies. This abnormality is limited to the myocardium and
correlates with the severity of both heart failure and elec-
trical instability. However, the mechanisms of the accumu-
lation of TE and its consequence on myocyte structure and
function need to be further elucidated.
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